A rational way for selecting the number of DEG with significant p-value for GSEA
2
0
Entering edit mode
@shamim-sarhadi-9395
Last seen 7.3 years ago

suppose I have 1000 prob-id(output of the limma) with the significant p-value, should all of them be select for GSEA, or there is a rational way of choosing the number of DEG for GSEA?

GSEA DEG • 1.6k views
ADD COMMENT
1
Entering edit mode
@steve-lianoglou-2771
Last seen 14 months ago
United States

The nice thing about some GSEA methods (like camera and roast) is that you don't need to choose a cutoff, but they rather work over the entire spectrum of changes across a comparison specified in your linear model.

Consider reading through the Gene set analysis and the Gene set testing sections in the PH525x biomedical science book

ADD COMMENT
0
Entering edit mode
@gordon-smyth
Last seen 1 hour ago
WEHI, Melbourne, Australia

Since you are analyzing a gene list, I assume that you are doing a simple overlap pathway analysis such as that done by the goana() or kegga() functions in limma. (I wouldn't call these methods GSEA, that's a term I prefer to reserve for more complicated things that are analogous to the GSEA software form the Broad Institute.)

The overlap analyses, whereby we count the number of DE genes in each annotated term or pathway, work best when there are lots of DE genes. So having 1000 DE genes is not by any means too many. However, a few thousand DE genes would be on the high side. In that case, I would trim the list down by using treat() with a higher lfc threshold.

ADD COMMENT
0
Entering edit mode

Thank you, Gordon Smyth

Your explanation was interesting, well I could try with Broad Institute 

software , http://software.broadinstitute.org/gsea/index.jsp

ADD REPLY
1
Entering edit mode

Or, since you already are using limma, you could try some of the many GSEA methods it provides as I suggested above (camera, roast, romer, ...)

ADD REPLY

Login before adding your answer.

Traffic: 685 users visited in the last hour
Help About
FAQ
Access RSS
API
Stats

Use of this site constitutes acceptance of our User Agreement and Privacy Policy.

Powered by the version 2.3.6